VISCHER advises e-hoi AG on the acquisition of Cruise Center AG
Cruise Center AG, a Swiss company that has been selling cruises for over twenty years, was acquired by the cruise agency e-hoi with retroactive effect from 1 January 2022.
e-domizil GmbH sold to HomeToGo SE for EUR 40m
e-vacation Group Holding GmbH sold e-domizil GmbH for EUR 40m to HomeToGo SE
VISCHER advises ADVANZ PHARMA on its USD 450m acquisition of Intercept
VISCHER has advised ADVANZ PHARMA, a specialty pharmaceutical company headquartered in London, on all Swiss legal aspects of its USD 450m acquisition of the ex-US business of Intercept Pharmaceuticals, spanning from due diligence to transactional document advice.
Andean Telecom Partners acquires BTS Towers
Andean Telecom Partners ("ATP"), a leading owner and operator of telecommunications infrastructure in the Andean Region, acquired BTS Towers ("BTS"), a privately owned provider of telecommunications infrastructure, headquartered...
VISCHER advises on MBO of Ulysse Nardin & Girard-Perregaux
On January 24, 2022, Kering entered into an agreement for the sale of its entire stake (100%) in Sowind Group SA, which owns the Swiss watch manufacturers Girard-Perregaux and Ulysse Nardin, to its current management.
VISCHER...
FairCap has acquired NYCO Flexible Packaging GmbH
FairCap, Germany, has acquired NYCO Flexible Packaging GmbH, Switzerland, from Clondalkin Group, a subsidiary of the Dutch investment company Egeria.
Gilde Buy Out Partners joins forces with Founders and Management of MBK
Funds advised by Gilde Buy Out Partners, a leading European private equity investor, completed the investment in MBK Fincom ("MBK" or the "Company"), alongside the founders and management which are reinvesting in the business....
Rigeto Investors acquired Laser Beauté Med SA
A group of investors advised by Rigeto Unternehmerkapital GmbH has acquired 100% of the shares in Laser Beauté Med SA, headquartered in Sion with additional locations in Monthey and Visp.
Sale of deepCDR Biologics AG to Alloy Therapeutics Inc.
deepCDR Biologics AG, ein in Basel ansässiges Start-Up, das sich auf die Entdeckung und Entwicklung von Antikörpern spezialisiert hat, wurde von Alloy Therapeutics Inc., ein in Boston ansässiges Biotechnologieunternehmen, übernommen.
Orell Füssli Thalia AG acquires a stake in Evrlearn AG
Orell Füssli Thalia AG acquired a stake as Lead Investor in the digital community platform Evrlearn AG.